MKMats KarlssonPhD, FCP, FISoPSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Impact of Immortal Time and Selection Bias on Exposure-response Modelling - Mats Karlsson, PhD, FCP, FISoPView Slideset
PvdGPiet van der GraafPharmD, PhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019How System Pharmacology Can Facilitate Clinical Drug Development in Oncology - Piet van der Graaf, PharmD, PhDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Comprehensive Pan-Cancer Analysis of Somatic Mutations in Drug Transporters to Reveal Acquired and Intrinsic Drug Resistance in 3149 Metastatic Cancer Patients - Wesley van de GeerView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Epigenetic Regulation of OCTN1-mediated Cytarabine Transport in Acute Myeloid Leukemia - Jason AndersonView Slideset
AJAnnelies Jorritsma-SmitPharmD, PhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019The Use of Radiolabeled and Fluorescent Monoclonal Antibodies for Molecular Imaging in Oncology - Annelies Jorritsma-Smit, PharmD, PhDView Slideset
JSJack SchalkenPhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019The Long and Winding Road of the Clinical Introduction of a Biomarker - Jack Schalken, PhDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Prediction of Capecitabine induced Severe Toxicity using Machine Learning Techniques - Maël SteunouView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Long Term Pemetrexed-based Cancer Treatment Leads to Nephrotoxicity - Nikki de RouwView Slideset
RPRuth PlummerMD, PhDSlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019Changes and Challenges in Early Phase Trial Endpoints - Ruth Plummer, MDView Slideset
SlidesetOncologyInternational Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019New Designs for Early Clinical Trials of IO Drugs - Emiliano Calvo, Md, PhDView Slideset
AbstractHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019Protein binding determination of second-line anti-tuberculosis drugs in vitro using an ultrafiltration techniqueView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019Comparison of a Bayesian forecasting algorithm handling inter-occasion variability and a linear regression approach for dose individualization of rifampicinView Abstract
